$CVS (CVS Asset) Support & Resistance Levels, AI Price Target & Institutional Flow.
Today, $CVS (CVS Asset) trades at $80.00 (+1.00%) with a 64/100 Momentum Pulse (BULLISH FLOW) and 14D RSI at 39 (PULLBACK ZONE (39)). Unlock the live $CVS support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $CVS.
Spot Price: $80.00 | 30-Day Support Floor: $79.96 (0.05% above) | 10-Day EMA: $84.38 | 20-Day SMA Pivot: $86.94 | 30-Day Resistance Ceiling: $94.48 (18.10% below) | 14-Day RSI: 39 (PULLBACK ZONE (39)) | 30-Day Trading Corridor: 18.16% span. Value and mean-reversion buyers in CVS ($CVS) are monitoring the $79.96 30-day mechanical support floor (spot price at $80.00 sits 0.05% above support with 14-day RSI at 39 (PULLBACK ZONE (39))). Reclaiming the 10-day EMA ($84.38) and 20-day SMA pivot ($86.94) is the primary technical trigger to ignite a move back toward the $94.48 resistance ceiling.
$CVS (CVS Asset) Live Key Levels, RSI & Valuation Matrix
| $CVS Technical Metric | Live Value | $CVS Fundamental / Regime Metric | Live Status |
|---|---|---|---|
| Live Spot Price (24h Change) | $80.00 (+1.00%) | Market Capitalization | $103.39B |
| 30-Day Mechanical Support Floor (Put Wall) | $79.96 (0.05% cushion) | 52-Week High / Low Range | $69.51 – $110.68 |
| 20-Day Simple Moving Average (20D SMA) | $86.94 | Trailing P/E Ratio & Dividend Yield | 9.37x • Yield: 3.29% |
| 10-Day Exponential Moving Average (10D EMA) | $84.38 | Average Daily Volume (Liquidity) | 8.54M shares |
| 30-Day Resistance Ceiling (Call Wall) | $94.48 (18.10% upside to test) | Next Scheduled Earnings / Catalyst Window | 2026-11-04 |
| 14-Day Relative Strength Index (RSI) | PULLBACK ZONE (39) | Saku Momentum Pulse & Health Rating | 64/100 Momentum • 74/100 Health |
Should You Buy $CVS Stock Now or Wait?
Value and mean-reversion buyers in CVS ($CVS) are monitoring the $79.96 30-day mechanical support floor (spot price at $80.00 sits 0.05% above support with 14-day RSI at 39 (PULLBACK ZONE (39))). Reclaiming the 10-day EMA ($84.38) and 20-day SMA pivot ($86.94) is the primary technical trigger to ignite a move back toward the $94.48 resistance ceiling.
$CVS (CVS) is currently trading below its 20-day simple moving average ($86.94) after a -7.22% 30-day move. If buyers fail to defend the 30-day mechanical support floor at $79.96 (0.05% above current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($69.51).
$CVS Support & Resistance, Institutional Flow & Catalysts.
$CVS Support & Resistance
Spot Price: $80.00 | 30-Day Support Floor: $79.96 (0.05% above) | 10-Day EMA: $84.38 | 20-Day SMA Pivot: $86.94 | 30-Day Resistance Ceiling: $94.48 (18.10% below) | 14-Day RSI: 39 (PULLBACK ZONE (39)) | 30-Day Trading Corridor: 18.16% span.
$CVS Institutional & Whale Flow
Institutional order flow for $CVS (averaging 8.54M shares daily volume) is concentrated between the $79.96 Put Wall support zone and $94.48 Call Wall resistance ceiling, with a live Saku Fundamental Health score of 74/100.
$CVS Catalyst Outlook
Next scheduled earnings window for CVS ($CVS): 2026-11-04. Latest tracked headline from kalkinemedia.com: "Can CVS Health (NYSE:CVS) Rise Above The Broader Pullback?".
Latest $CVS (CVS Asset) Breaking News & Headlines
About CVS Asset ($CVS)
CVS Caremark Corporation (CVS Caremark), together with its subsidiaries, is a pharmacy health care provider in the United States. CVS Caremark provides pharmacy services through its pharmacy benefit management (PBM), mail order and specialty pharmacy division, CVS Caremark Pharmacy Services; approximately 7,300 CVS/pharmacy retail stores; retail-based health clinic subsidiary, MinuteClinic, and its online retail pharmacy, CVS.com. The Company operates in three business segments: Pharmacy Services, Retail Pharmacy and Corporate. Its corporate segment provides management and administrative services to support the overall operations of the Company. In April 2012, Health Net, Inc.'s subsidiary, Health Net Life Insurance Company, sold its Medicare stand-alone Prescription Drug Plan (Medicare PDP) business to a subsidiary of CVS Caremark. In February 2013, it bought Drogaria Onofre.
Saku's quantitative engine continuously monitors $CVS's 30-day mechanical support floor ($79.96), 20-day simple moving average ($86.94), and 30-day resistance ceiling ($94.48) alongside off-exchange dark pool block prints and SEC filings.
Hatch Your Own 24/7 AI Co-Pilot to Guard $CVS.
Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $CVS 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

What are the live 30-day support and resistance levels for $CVS (CVS Asset)?
Spot Price: $80.00 | 30-Day Support Floor: $79.96 (0.05% above) | 10-Day EMA: $84.38 | 20-Day SMA Pivot: $86.94 | 30-Day Resistance Ceiling: $94.48 (18.10% below) | 14-Day RSI: 39 (PULLBACK ZONE (39)) | 30-Day Trading Corridor: 18.16% span. $CVS currently registers a Saku Momentum Pulse score of 64/100 and a Fundamental Health score of 74/100.
Why is $CVS (CVS Asset) moving and what is the bull vs. bear thesis?
Bull Thesis: Value and mean-reversion buyers in CVS ($CVS) are monitoring the $79.96 30-day mechanical support floor (spot price at $80.00 sits 0.05% above support with 14-day RSI at 39 (PULLBACK ZONE (39))). Reclaiming the 10-day EMA ($84.38) and 20-day SMA pivot ($86.94) is the primary technical trigger to ignite a move back toward the $94.48 resistance ceiling. Bear Thesis: $CVS (CVS) is currently trading below its 20-day simple moving average ($86.94) after a -7.22% 30-day move. If buyers fail to defend the 30-day mechanical support floor at $79.96 (0.05% above current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($69.51).
What are $CVS's key fundamentals, 52-week range, and upcoming catalysts?
CVS Asset ($CVS) trades with a market cap of $103.39B, a P/E ratio of 9.37x, and a 52-week range of $69.51 to $110.68. Next scheduled earnings window for CVS ($CVS): 2026-11-04. Latest tracked headline from kalkinemedia.com: "Can CVS Health (NYSE:CVS) Rise Above The Broader Pullback?".